Amedisys to Present at the 41st Annual J.P. Morgan Healthcare Conference

BATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 8:15 p.m. ET (5:15 p.m. PT).

To access a live webcast of the Amedisys presentations, please log on through our website at http://investors.amedisys.com.

About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 547 care centers in 36 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: www.amedisys.com.

Contact:  
Nick Muscato Kendra Kimmons
Amedisys, Inc. Amedisys, Inc.
Investor Relations  Media Relations
615.928.5452   225.299.3720
nick.muscato@amedisys.com Kendra.kimmons@amedisys.com

Staff

Recent Posts

Emet Surgical Accepted into Innosphere Ventures Life Sciences Incubator Program

DENVER--(BUSINESS WIRE)--Emet Surgical, developers of innovative tools to improve surgery outcomes, today announced its acceptance…

9 mins ago

Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Edmonton, Alberta--(Newsfile Corp. - April 9, 2024) - Entos Pharmaceuticals, (Entos), a genetic medicines company…

10 mins ago

Chadwick Robertson, Pharmacist, Highlighted for Pioneering Renewable Energy in Healthcare Facilities

VANCOUVER, BC / ACCESSWIRE / April 9, 2024 / In a brand new online article…

10 mins ago

My Quest Story – Jessica Clow

NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / Quest Diagnostics:I began working at Quest…

10 mins ago

Transforming Healthcare with Generative AI and LLMs: Insights from Industry Leaders Webinar

Listen to full webinar here HOSTED BY Ben MaisanoSVP, Head of Strategy, Tendo. Formerly of…

2 hours ago

IMPLANET Reports its 2024 First-Quarter Revenue

+10% growth in the French market vs. 2023 Q1 Continued expansion of the SMTP surgical…

3 hours ago